Comparative pharmacodynamic evaluation of eptifibatide and tirofiban HCl in patients undergoing percutaneous coronary intervention (the TAM1 Study).

Saucedo, Jorge F; Garza, Luis; Wolford, David C; Cook, Stephen L; Ramanathan, Kodangudi B; Matin, Zakaria; McGrew, Frank A; Jacoski, Mary V; Jennings, Lisa K

Saucedo, Jorge F; Garza, Luis; Wolford, David C; Cook, Stephen L; Ramanathan, Kodangudi B; Matin, Zakaria; McGrew, Frank A; Jacoski, Mary V; Jennings, Lisa K.

Affiliation

Saucedo JF; University of Arkansas for Medical Sciences and Central Arkansas Veterans Health Care System, Little Rock, AR, USA.

Am J Cardiol ; 93(10): 1279-82, 2004 May 15.

Article in En | MEDLINE | ID: mdl-15135704

Subject(s)

Angioplasty, Balloon, Coronary; Coronary Artery Disease/therapy; Peptides/pharmacology; Platelet Aggregation Inhibitors/pharmacology; Platelet Aggregation/drug effects; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Tyrosine/analogs & derivatives; Tyrosine/pharmacology; Arkansas; Eptifibatide; Female; Humans; Infusions, Intravenous; Male; Mississippi; Peptides/administration & dosage; Platelet Aggregation Inhibitors/administration & dosage; Tennessee; Tirofiban; Tyrosine/administration & dosage; United States

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Peptides / Tyrosine / Coronary Artery Disease / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Platelet Aggregation / Platelet Glycoprotein GPIIb-IIIa Complex Type of study: Clinical_trials Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Year: 2004 Type: Article

Search on Google

XML

PubMed Links